✦ LIBER ✦
Feasibility and benefit of hydroxycarbamide as a long-term treatment for sickle cell disease patients: Results from the North West London Sickle Cell Disease Registry
✍ Scribed by Annette Gilmore; Gavin Cho; Jo Howard; Mark Layton; Michele Afif; Robert George Hughes; Nicola J Philpott; Sameer Patankar; Sally C. Davies; the North West London Haemoglobinopathy Registry Group
- Book ID
- 118281307
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 324 KB
- Volume
- 86
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.